AU2847199A - Crystalline form of paroxetine - Google Patents
Crystalline form of paroxetine Download PDFInfo
- Publication number
- AU2847199A AU2847199A AU28471/99A AU2847199A AU2847199A AU 2847199 A AU2847199 A AU 2847199A AU 28471/99 A AU28471/99 A AU 28471/99A AU 2847199 A AU2847199 A AU 2847199A AU 2847199 A AU2847199 A AU 2847199A
- Authority
- AU
- Australia
- Prior art keywords
- paroxetine
- free base
- crystalline
- product
- paroxetine free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9805581.7A GB9805581D0 (en) | 1998-03-16 | 1998-03-16 | Novel compounds |
GB9805581 | 1998-03-16 | ||
GBGB9813054.5A GB9813054D0 (en) | 1998-06-17 | 1998-06-17 | Novel compounds |
GB9813054 | 1998-06-17 | ||
GBGB9817115.0A GB9817115D0 (en) | 1998-08-06 | 1998-08-06 | Novel compounds |
GB9817115 | 1998-08-06 | ||
PCT/GB1999/000793 WO1999047519A1 (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2847199A true AU2847199A (en) | 1999-10-11 |
Family
ID=27269245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28471/99A Abandoned AU2847199A (en) | 1998-03-16 | 1999-03-16 | Crystalline form of paroxetine |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1064282A1 (xx) |
JP (1) | JP2002506865A (xx) |
KR (1) | KR20010041947A (xx) |
CN (1) | CN1300286A (xx) |
AP (1) | AP2000001907A0 (xx) |
AU (1) | AU2847199A (xx) |
BG (1) | BG104839A (xx) |
BR (1) | BR9908825A (xx) |
CA (1) | CA2323896A1 (xx) |
EA (1) | EA200000946A1 (xx) |
HU (1) | HUP0101215A3 (xx) |
ID (1) | ID27596A (xx) |
IL (1) | IL138390A0 (xx) |
NO (1) | NO20004583L (xx) |
PL (1) | PL342931A1 (xx) |
SK (1) | SK13622000A3 (xx) |
TR (1) | TR200002675T2 (xx) |
WO (1) | WO1999047519A1 (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH689805A8 (fr) * | 1998-07-02 | 2000-02-29 | Smithkline Beecham Plc | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. |
GB9919052D0 (en) * | 1999-08-12 | 1999-10-13 | Smithkline Beecham Plc | Novel compound composition and process |
US20080033050A1 (en) | 2006-08-04 | 2008-02-07 | Richards Patricia Allison Tewe | Method of treating thermoregulatory disfunction with paroxetine |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
AR001982A1 (es) * | 1995-02-06 | 1998-01-07 | Smithkline Beecham Plc | Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion |
-
1999
- 1999-03-16 IL IL13839099A patent/IL138390A0/xx unknown
- 1999-03-16 BR BR9908825-8A patent/BR9908825A/pt not_active Application Discontinuation
- 1999-03-16 JP JP2000536714A patent/JP2002506865A/ja active Pending
- 1999-03-16 CA CA002323896A patent/CA2323896A1/en not_active Abandoned
- 1999-03-16 KR KR1020007010260A patent/KR20010041947A/ko not_active Application Discontinuation
- 1999-03-16 EP EP99909104A patent/EP1064282A1/en not_active Withdrawn
- 1999-03-16 ID IDW20001813A patent/ID27596A/id unknown
- 1999-03-16 SK SK1362-2000A patent/SK13622000A3/sk unknown
- 1999-03-16 HU HU0101215A patent/HUP0101215A3/hu unknown
- 1999-03-16 AP APAP/P/2000/001907A patent/AP2000001907A0/en unknown
- 1999-03-16 AU AU28471/99A patent/AU2847199A/en not_active Abandoned
- 1999-03-16 TR TR2000/02675T patent/TR200002675T2/xx unknown
- 1999-03-16 CN CN99806077A patent/CN1300286A/zh active Pending
- 1999-03-16 EA EA200000946A patent/EA200000946A1/ru unknown
- 1999-03-16 PL PL99342931A patent/PL342931A1/xx unknown
- 1999-03-16 WO PCT/GB1999/000793 patent/WO1999047519A1/en not_active Application Discontinuation
-
2000
- 2000-09-14 NO NO20004583A patent/NO20004583L/no not_active Application Discontinuation
- 2000-10-11 BG BG104839A patent/BG104839A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20010041947A (ko) | 2001-05-25 |
BG104839A (en) | 2001-09-28 |
WO1999047519A1 (en) | 1999-09-23 |
TR200002675T2 (tr) | 2000-12-21 |
BR9908825A (pt) | 2000-11-21 |
ID27596A (id) | 2001-04-12 |
PL342931A1 (en) | 2001-07-16 |
EP1064282A1 (en) | 2001-01-03 |
AP2000001907A0 (en) | 2000-09-30 |
CN1300286A (zh) | 2001-06-20 |
CA2323896A1 (en) | 1999-09-23 |
HUP0101215A2 (hu) | 2002-04-29 |
IL138390A0 (en) | 2001-10-31 |
NO20004583L (no) | 2000-09-15 |
HUP0101215A3 (en) | 2002-05-28 |
JP2002506865A (ja) | 2002-03-05 |
EA200000946A1 (ru) | 2001-02-26 |
SK13622000A3 (sk) | 2001-03-12 |
NO20004583D0 (no) | 2000-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0808314B1 (en) | Forms of paroxetin hydrochloride | |
US5856493A (en) | Process for making novel form of paroxeting hydrochloride anhydrate | |
EA025438B1 (ru) | КРИСТАЛЛИЧЕСКИЙ КОМПЛЕКС 1-ЦИАНО-2-(4-ЦИКЛОПРОПИЛБЕНЗИЛ)-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)БЕНЗОЛА, СПОСОБЫ ЕГО ПОЛУЧЕНИЯ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
GB2367003A (en) | Paroxetine methansulphonate compositions | |
US20150266860A1 (en) | Crystalline form of a drug | |
US20060189675A1 (en) | Crystalline form of a drug | |
US20060063825A1 (en) | Crystalline form of a drug | |
EP1137636A1 (en) | Process for preparation of paroxetine maleate | |
WO2000035910A1 (en) | Derivative of paroxetine | |
AU2847199A (en) | Crystalline form of paroxetine | |
CA2164296C (en) | Heterocyclic chemistry | |
JPH09500139A (ja) | ヒドロキシルアミンの酸付加塩の合成法 | |
MXPA00009137A (es) | Forma cristalina de paroxetina | |
WO2000032593A1 (en) | Method of producing paroxetine hydrochloride | |
EP1135383B1 (en) | Mixed paroxetine propan-2-ol solvates | |
AU1769899A (en) | Process for the preparation of paroxetine hydrochloride | |
CZ20003343A3 (cs) | Krystalická forma paroxetinu | |
US20020137938A1 (en) | Novel process | |
WO2001012623A1 (en) | Process for the preparation of paroxetine hydrochloride | |
WO2000032595A1 (en) | Process for the production of paroxetine hydrochloride acetone solvate | |
WO2001025201A1 (en) | Process for the preparation of paroxetin intermediate | |
WO2000039090A1 (en) | Process for the preparation of paroxetine acetate and analogues thereof | |
WO2000032592A1 (en) | Process for the preparation of paroxetine hydrochloride | |
WO2000032596A1 (en) | Amine salts of paroxetine | |
MXPA00006040A (en) | Process for the preparation of paroxetine hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |